EC
TMO icon

Enhancing Capital’s Thermo Fisher Scientific TMO Stock Holding History

Enhancing Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$325K Buy
649
+143
+28% +$68.6K 0.22% 76
2026
Q1 		$249K Hold
506
– – 0.18% 78
2025
Q4 		$293K Sell
506
-16
-3% -$9.05K 0.21% 78
2025
Q3 		$253K Buy
+522
New +$243K 0.19% 77
2025
Q2 		– Sell
-412
Closed -$205K – 94
2025
Q1 		$205K Buy
+412
New +$223K 0.16% 91

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Enhancing Capital's TMO Position: Q2 2026 in Review

Enhancing Capital increased its Thermo Fisher Scientific (TMO) stake by 28% in Q2 2026, buying an estimated $68.6K and bringing the position to 649 shares worth $325K. The position accounts for 0.22% of the portfolio, ranked #76.

Enhancing Capital first reported a position in TMO in Q1 2025 and has held it in 5 quarters since. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Enhancing Capital held 649 shares of Thermo Fisher Scientific worth $325K as of Q2 2026.
  • Enhancing Capital bought 143 Thermo Fisher Scientific shares in Q2 2026, an estimated $68.6K.
  • Thermo Fisher Scientific made up 0.22% of Enhancing Capital's portfolio in Q2 2026, its #76 holding.
  • Enhancing Capital first reported a position in Thermo Fisher Scientific in Q1 2025 and has held it in 5 quarters since.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Enhancing Capital's 13F filing for Q2 2026, filed 11 Aug 2026.